Communicable diseases affect low and middle income countries disproportionately, often the most vulnerable population (children, pregnant women, elderly and immunocompromised), living in low resource settings.
While the applications of CRISPR in healthcare has been termed “disruptive”, an equally compelling area for research is in exploring applications on addressing climate change problems.
CAR- T therapy heralds a new and innovative approach to cancer immunotherapy. The core concept is to reprogram a patient’s T cells externally with chimeric antigen receptors (CARs) that are then transfused back into the patient.
CRISPR genome editing technology has allowed scientists to perform a number of complex experiments with speed and accuracy more than ever before.